Tech Company Financing Transactions
Quantum Immunologics Funding Round
Quantum Immunologics, operating out of Tampa, secured $2.3 million in funding from private investors.
Transaction Overview
Company Name
Announced On
9/26/2010
Transaction Type
Venture Equity
Amount
$2,302,784
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1881 W. Kennedy Blvd. PO Box 20727
Tampa, FL 33623
USA
Tampa, FL 33623
USA
Phone
Website
Email Address
Overview
Quantum Immunologics is in the process of developing an immunologic treatment for breast cancer that may have positive effects on other types of cancer as well. Phase I and II clinical trials are currently under way in Mobile Alabama. The current trial has a patient base of 27 women with stage IV breast cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Executive Vice President
Barry Roth
President
Josh Coughlin
VP - Finance
Don Wright
VP - Marketing
Timothy Schwiers
VP - Operations
Taina Broes
Browse more venture capital transactions:
Prev: 9/26/2010: Rhythmia Medical venture capital transaction
Next: 9/26/2010: Chegg venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs